GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aurora Cannabis ACB.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

7.30

-1.35%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2026

Revenue

C$320.6m

FY2017FY2026

Net income

−C$121.8m

FY2017FY2026

Free cash flow

−C$36.1m

FY2017FY2026

Shareholders' equity

C$513.2m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueC$320.6mC$343.3mC$270.3mC$223.8mC$221.3mC$245.3mC$268.7mC$245.5mC$55.2mC$18.1m
Research and developmentC$4.0mC$3.7mC$3.6mC$5.8mC$10.4mC$11.4mC$26.0mC$14.8mC$1.7mC$314,000
Operating income−C$46.7mC$4.9m−C$58.2m−C$187.6m−C$231.4m−C$633.4m−C$465.8m−C$293.3mC$88.0m−C$11.5m
Net income−C$121.8mC$1.6m−C$69.3m−C$816.6m−C$1.74bn−C$693.6m−C$3.28bn−C$293.5mC$71.9m−C$13.0m
Diluted earnings per share-1.970.03-1.24-17.22-51.01-34.99-195.40-32.358.91-3.83

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsC$602.6mC$847.8mC$840.1mC$926.4mC$926.4mC$2.72bnC$2.92bnC$5.64bnC$1.90bnC$323.8m
Cash and short-term investmentsC$165.1mC$184.8mC$183.6mC$300.9mC$300.9mC$444.0mC$168.5mC$363.4mC$150.4mC$175.3m
Total liabilitiesC$89.5mC$242.7mC$237.2mC$404.6mC$404.6mC$686.0mC$802.6mC$1.23bnC$335.9mC$104.1m
DebtC$5.7mC$104.6mC$104.8mC$227.5mC$347.2mC$334.1mC$530.6mC$645.8mC$203.2mC$63.9m
Shareholders' equityC$513.2mC$563.9mC$560.7mC$490.7mC$490.7mC$2.04bnC$2.14bnC$4.40bnC$1.56bnC$219.7m
Shares outstanding62m57m56m47m34m20m17m9m8m3m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−C$13.5mC$16.0m−C$68.5m−C$85.6m−C$110.3m−C$210.6m−C$342.1m−C$192.2m−C$81.7m−C$13.4m
Capital spending−C$22.5m−C$18.9m−C$16.8m−C$6.9m−C$32.2m−C$53.1m−C$348.8m−C$414.2m−C$136.9m−C$25.7m
Free cash flow−C$36.1m−C$2.9m−C$85.3m−C$92.5m−C$142.5m−C$263.7m−C$691.0m−C$606.4m−C$218.6m−C$39.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueC$67.6mC$38.1mC$94.2mC$90.4mC$88.2mC$90.5mC$88.2mC$81.1m
Operating income−C$47.5m−C$25.2mC$4.8m−C$44.8mC$36.9m−C$30.4mC$36.9m−C$2.4m
Net income−C$4.0m−C$57.0mC$1.8m−C$51.5mC$31.7m−C$24.6mC$31.7m−C$12.0m
Diluted earnings per share-0.07-0.920.03-0.900.55-0.430.57-0.22
Cash from operations−C$4.0m—C$16.0m−C$40.0mC$10.0mC$3.0mC$28.0m−C$24.0m
Capital spending−C$5.0m−C$5.0m−C$5.0m−C$6.0m−C$5.0m−C$4.0m−C$4.0m−C$4.0m
Free cash flow−C$9.0m—C$11.0m−C$46.0mC$5.0m−C$1.0mC$24.0m−C$28.0m
Total assetsC$621.1mC$602.6mC$775.3mC$756.9mC$841.9mC$847.8mC$865.9mC$807.5m
Cash and short-term investmentsC$149.2mC$165.1mC$108.5mC$95.7mC$186.9mC$184.8mC$180.1mC$151.4m
DebtC$5.9mC$5.7mC$67.8mC$65.3mC$65.6mC$66.9mC$64.0mC$62.5m
Shareholders' equityC$527.4mC$513.2mC$536.4mC$531.9mC$554.6mC$563.9mC$572.5mC$542.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue12.7%5.5%71.7%
Operating income-37.1%-40.6%26.3%
Net income-47.0%-29.4%35.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-6.3%-24.8%-70.9%-83.1%
Net margin-18.1%-86.9%-211.7%-314.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-3.7207.9-4.9-0.4-0.3-1.2-0.3-6.456.3-185.6
Price to sales1.41.01.31.41.93.44.17.673.4133.2

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 20 Feb 2024
  • 12-to-1 reverse split · 11 May 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.